1. Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12:31–46
2. Pearlman AH, Hwang MS, Konig MF et al (2021) Targeting public neoantigens for cancer immunotherapy. Nat Cancer 2:487–497
3. Faubert B, Solmonson A, DeBerardinis RJ (2020) Metabolic reprogramming and cancer progression. Science 368:eaaw5473
4. Walrath JC, Hawes JJ, Van Dyke T, Reilly KM (2010) Genetically engineered mouse models in cancer research. In: Advances in cancer research, vol 106. Academic Press, pp 113–164
5. Waterston RH, Lindblad-Toh K, Birney E et al (2002) Initial sequencing and comparative analysis of the mouse genome. Nature 420:520–562